Skip to main content

Table 1 Characteristics of the ovarian cancer patient cohort measured at the diagnosis date

From: Trends in platelet count among cancer patients

Description

Value

Number of patients

 

6451

Year of diagnosis

Mean (SD)

2011.5 (2.4)

Median (IQR)

2012 (2009-2014)

Age

Mean (SD)

62.2 (14.9)

Median (IQR)

62.6 (52.0–72.9)

Residence setting

Urban

5733 (88.9%)

Rural

712 (11.0%)

Missing

6 (0.1%)

Primary care visits to general practitioner in previous 2 years

Mean (SD)

3.1 (3.3)

Median (IQR)

2 (1–4)

Comorbidities

Asthma

582 (9.0%)

Congestive heart failure

301 (4.7%)

Hypertension

2922 (45.3%)

Diabetes

806 (12.5%)

Dementia

164 (2.5%)

Number of concurrent medications used

Mean (SD)

3.9 (3.1)

Median (IQR)

3 (2-6)

Cancer stage

I

1140 (17.7%)

II

496 (7.7%)

III

2189 (33.9%)

IV

801 (12.4%)

Unknown

1825 (28.3%)

Number of CBCs during the observation period

Mean (SD)

12.0 (16.0)

Median (IQR)

6 (2–15)

Number of CBCs in the 2 years prior to diagnosis

Mean (SD)

2.0 (2.8)

Median (IQR)

1 (0–3)

Number of CBCs in the 2 years after diagnosis

Mean (SD)

10.0 (15.4)

Median (IQR)

4 (1–13)

Ovarian cancer death within 3 years of diagnosis

Yes

2302 (35.7%)